Dr. Camilia Martin named chief of new child med

picture: Dr. Camilia Martin
view extra 

Credit score: Dr. Camilia Martin

Dr. Camilia Martin, an esteemed physician-scientist who combines medical care and modern analysis on neonatal diet to enhance outcomes for untimely and new child infants, has been named chief of the Division of New child Drugs at Weill Cornell Drugs and NewYork-Presbyterian Komansky Youngsters’s Hospital, efficient Might 1.

The Division of New child Drugs is housed inside the Division of Pediatrics at Weill Cornell Drugs and affiliated with NewYork-Presbyterian Alexandra Cohen Hospital for Ladies and Newborns. The neonatal crew delivers greater than 7,300 infants yearly and supplies individualized take care of infants born with issues or abnormalities and moms with high-risk circumstances that complicate being pregnant. Utilizing state-of-the-art expertise and dealing in collaboration with quite a few subspecialists, the division’s neonatal outcomes, together with mortality and issues of prematurity, exceed worldwide benchmarks on this space of care. Dr. Martin succeeds Dr. Jeffrey Perlman, who has led the division since 1997, and can stay on college, growing his deal with international well being applications.

In her new function, Dr. Martin will lead a talented crew of physicians and scientists targeted on medical care, analysis and schooling in key areas of new child drugs. She’s going to search to develop affected person entry to new child companies, prioritize the household’s voice and expertise within the neonatal intensive care unit (NICU), and develop a brand new strategic plan for streamlining medical care. She can even work to develop the establishment’s neonatal analysis applications and domesticate the following technology of physician-scientists specializing in new child drugs. 

Dr. Martin involves Weill Cornell Drugs and NewYork-Presbyterian Komansky Youngsters’s Hospital from Beth Israel Deaconess Medical Heart in Boston, the place she served most lately as affiliate director of the neonatal intensive care unit and affiliate professor of pediatrics at Harvard Medical College. She is a Weill Cornell Drugs alumna, graduating in 1992, and likewise an alumna of the establishment’s Vacationers Summer season Analysis Fellowship Program, which supplies publicity to drugs, analysis expertise and mentorship to premedical college students from underrepresented backgrounds.  

“We’re thrilled to welcome Dr. Martin as our new chief of new child drugs,” mentioned Dr. Sallie Permar, chair of the Division of Pediatrics at Weill Cornell Drugs and pediatrician-in-chief at NewYork-Presbyterian Komansky Youngsters’s Hospital. “As an impressive neonatal specialist, scientist, mentor and educator who has pushed crucial advances in neonatal care, Dr. Martin is a perfect alternative for the place. I stay up for working together with her as we develop our specialised companies targeted on bettering the well being of our youngest, and sometimes most susceptible, sufferers.”

“I’m excited to return to Weill Cornell Drugs and NewYork-Presbyterian Komansky Youngsters’s Hospital to guide the Division of New child Drugs,” Dr. Martin mentioned. “It’s an honor to have a possibility to provide again to the establishment the place I obtained my begin in drugs and contribute to its progress and future. The division’s emphasis on medical excellence and funding within the pillars of analysis, schooling and group outreach symbolize a singular alternative within the discipline.” 

Dr. Martin’s analysis focuses on neonatal metabolism and diet and the way they have an effect on the well being of infants born prematurely. Particularly, she investigates fatty acid metabolism, postnatal intestinal adaptation, the event of immune defenses and the regulation of inflammatory responses. She has served as website principal investigator in multi-site medical trials, together with the primary iteration of the landmark Extraordinarily Low Gestational Age New child (ELGAN) research, which has resulted in additional than 100 publications on progress and long-term neurodevelopmental outcomes in extraordinarily preterm infants.

Dr. Martin will faucet into present sources offered by the Weill Cornell Drugs Medical & Translational Science Heart and develop collaborative relationships with interdisciplinary researchers inside Weill Cornell Drugs, Cornell Tech, Columbia College Irving Medical Heart and The Rockefeller College.

“There’s a giant alternative to advance our understanding of how preterm infants course of and take in diet,” Dr. Martin mentioned. “As soon as we work out their explicit wants, we will develop extra particular diets and make key strides in bettering their capability to thrive.”

About Dr. Camilia Martin

Dr. Martin obtained her bachelor’s diploma from Washington College in St. Louis, medical diploma from Weill Cornell Drugs and grasp’s diploma in epidemiology from the Harvard T. H. Chan College of Public Well being at Harvard College. She accomplished her internship and residency after which served as chief pediatric resident on the Ann & Robert H. Lurie Youngsters’s Hospital of Chicago, adopted by a medical fellowship in neonatal-perinatal drugs at Harvard College.

Starting in 1995, Dr. Martin has served as a doctor on the Ann & Robert H. Lurie Youngsters’s Hospital of Chicago and subsequently as a neonatal specialist at varied different hospitals, together with Boston Youngsters’s Hospital and Beth Israel Deaconess Medical Heart. She was an teacher in pediatrics on the Northwestern College Feinberg College of Drugs from 1995 to 1996, earlier than becoming a member of the pediatrics division at Harvard Medical College in 1999, first serving as teacher and rising to affiliate professor in 2016, her most up-to-date place.

Dr. Martin has co-authored greater than 70 articles revealed in main peer-reviewed journals. She has additionally authored and co-authored quite a few medical reference supplies, together with the Neonatology Overview ebook collection utilized by medical college students and nurse practitioners worldwide. Dr. Martin is a member of a number of medical organizations, together with the American Pediatric Society and the Perinatal Analysis Society. Since 2019, she has served as a member of the American Academy of Pediatrics’ Committee on the Fetus and New child. 

Dr. Martin has obtained quite a few awards, together with the Richard Rivas Memorial Award, the Biomedical Providers Profession Program Honor Roll and Senior Resident of the Yr on the Ann & Robert H. Lurie Youngsters’s Hospital of Chicago. She additionally obtained the School Fellowship Award from Harvard Catalyst/Harvard Medical College and lately the Harvard Neonatal-Perinatal Fellowship Honor Roll Award from Boston Youngsters’s Hospital.

Dr. Martin has been awarded a number of main grants for advancing neonatal diet analysis, together with a research supported by the Massachusetts Life Sciences Heart to judge the organic mechanisms contributing to dietary properties in human milk.                                       


NewYork-Presbyterian is among the nation’s most complete, built-in educational healthcare methods, encompassing 10 hospitals throughout the Larger New York space, almost 200 main and specialty care clinics and medical teams, and an array of telemedicine companies.

A pacesetter in medical schooling, NewYork-Presbyterian Hospital is the one educational medical middle within the nation affiliated with two world-class medical faculties, Weill Cornell Drugs and Columbia College Vagelos Faculty of Physicians and Surgeons. This collaboration means sufferers have entry to the nation’s main physicians, the complete vary of medical specialties, newest improvements in care, and analysis that’s creating cures and saving lives.

Ranked the #1 hospital in New York and the #7 hospital within the nation in U.S. Information & World Report’s Greatest Hospitals rankings, NewYork-Presbyterian Hospital can be acknowledged as among the many finest within the nation within the U.S. Information Greatest Youngsters’s Hospitals rankings. Based 250 years in the past, NewYork-Presbyterian Hospital has a protracted legacy of medical breakthroughs and innovation, from the invention of the Pap check to pioneering the groundbreaking coronary heart valve substitute process referred to as TAVR.

NewYork-Presbyterian’s 48,000 workers and affiliated physicians are devoted to offering the very best high quality, most compassionate care to New Yorkers and sufferers from throughout the nation and all over the world. For extra info, go to www.nyp.org and discover us on Fb, Twitter, Instagram, and YouTube.

Weill Cornell Drugs

Weill Cornell Drugs is dedicated to excellence in affected person care, scientific discovery and the schooling of future physicians in New York Metropolis and all over the world. The medical doctors and scientists of Weill Cornell Drugs — college from Weill Cornell Medical Faculty, Weill Cornell Graduate College of Medical Sciences, and Weill Cornell Doctor Group — are engaged in world-class medical care and cutting-edge analysis that join sufferers to the newest therapy improvements and prevention methods. Positioned within the coronary heart of the Higher East Aspect’s scientific hall, Weill Cornell Drugs’s highly effective community of collaborators extends to its dad or mum college Cornell College; to Qatar, the place Weill Cornell Drugs-Qatar gives a Cornell College medical diploma; and to applications in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Drugs college present exemplary affected person care at NewYork-Presbyterian/Weill Cornell Medical Heart, NewYork-Presbyterian Westchester Behavioral Well being Heart, NewYork-Presbyterian Decrease Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Drugs can be affiliated with Houston Methodist. For extra info, go to weill.cornell.edu.

Previous post Northwell Ranks Third on Quick Firm Most Progressive Well being Corporations For 2022 | Enterprise
Next post A Health Mannequin Tried Robert Pattinson’s ‘The Batman’ Eating regimen